drugset / Trial / NCT01939301
Nitric Oxide to Treat Pulmonary Embolism
Phase 2
Completed
78 enrolled
Indiana University
Mallinckrodt · collabNational Heart, Lung, and Blood Institute (NHLBI) · collabNational Institutes of Health (NIH) · collabUniversity of Mississippi Medical Center · collabUniversity of Texas, Southwestern Medical Center at Dallas · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized study to treat subjects diagnosed with pulmonary embolism with inhaled nitric oxide or placebo (oxygen).
Timeline
- Start
- 2013-10
- Primary completion
- 2016-10-31
- Completion
- 2016-10-31
Publications
- Kline JA, Puskarich MA, Jones AE, Mastouri RA, Hall CL, Perkins A, Gundert EE, Lahm T. Inhaled nitric oxide to treat intermediate risk pulmonary embolism: A multicenter randomized controlled trial. Nitric Oxide. 2019 Mar 1;84:60-68. doi: 10.1016/j.niox.2019.01.006. Epub 2019 Jan 8.
- Kline JA, Hall CL, Jones AE, Puskarich MA, Mastouri RA, Lahm T. Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial. Am Heart J. 2017 Apr;186:100-110. doi: 10.1016/j.ahj.2017.01.011. Epub 2017 Jan 27.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nitric Oxide | Other / unclassified | 50 ppm | Inhaled |